Innate Pharma: PACIFIC-9 phase 3 trial readout timing updated to H1 2027
Innate Pharma to participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
Innate Pharma announces conference call for third quarter 2026 business and financial update
Innate Pharma reports first half 2026 business update and financial results
Innate and Sobi announce partnership is now effective following completion of closing conditions
Innate Pharma to host conference call and webcast on september 17 for first half 2026 financial results and business update
Innate pharma to participate in the H.C. Wainwright 28th annual global investment conference
Innate Pharma announces conference call and webcast
Innate Pharma Announces Pricing of €30 million Offering of Ordinary Shares
Innate Pharma Announces Proposed Offering of Ordinary Shares
